1 | 18F-AV-1451 | - | - | - | - | 3件: 5 5, 7, 127 |
2 | 18F-FDG | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 8件: 5 5, 6, 7, 13, 84, 85, 127, 300 |
3 | 18F-RO6958948 | - | - | - | - | 3件: 5 5, 7, 127 |
4 | ABBV-8E12 | - | - | - | - | 2件: 5 5, 7 |
5 | AL | - | - | - | - | 11件: 5 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 |
6 | Anti-Parkinson medication | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
7 | Apomorphine | 1件: Apomorphine Apomorphine | 1件: D07460
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 5 5, 6, 7 |
8 | BIIB092 | - | - | - | - | 3件: 5 5, 7, 127 |
9 | BOTULINUM TOXIN TYPE A | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 10件: 2 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
10 | Davunetide | 1件: Davunetide Davunetide | 1件: D09401
D09401
| - | - | 3件: 5 5, 7, 127 |
11 | Davunetide (AL-108, NAP) | 1件: Davunetide Davunetide | 1件: D09401
D09401
| - | - | 3件: 5 5, 7, 127 |
12 | Dopamine | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 7, 74 |
13 | Fasudil | 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 5, 7, 51 |
14 | Flortaucipir | 1件: Flortaucipir Flortaucipir | 1件: D11210
D11210
| 1件: MAPT MAPT 💬 | 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 5 5, 7, 127 |
15 | Flortaucipir F18 | 1件: Flortaucipir Flortaucipir | 1件: D11210
D11210
| 1件: MAPT MAPT 💬 | 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 5 5, 7, 127 |
16 | Flutemetamol | 1件: Flutemetamol (18F) Flutemetamol (18F) | - | - | - | 4件: 5 5, 6, 7, 127 |
17 | Lithium | 1件: Lithium citrate Lithium citrate | 1件: D04749
D04749
| - | - | 5件: 2 2, 5, 6, 7, 8 |
18 | NT 101 | - | - | - | - | 4件: 5 5, 6, 7, 17 |
19 | Raclopride | 1件: Raclopride Raclopride | - | - | - | 4件: 5 5, 6, 7, 17 |
20 | TPI 287 | - | - | - | - | 2件: 5 5, 7 |
21 | TPI 287 2 mg/m2 | - | - | - | - | 2件: 5 5, 7 |
22 | TPI-287 | 1件: TPI-287 TPI-287 | - | - | - | 2件: 5 5, 7 |
23 | TPI-287 20 mg/m2 | 1件: TPI-287 TPI-287 | - | - | - | 2件: 5 5, 7 |
24 | TPI-287 6.3 mg/m2 | 1件: TPI-287 TPI-287 | - | - | - | 2件: 5 5, 7 |
25 | Vizamyl | 1件: Flutemetamol (18F) Flutemetamol (18F) | - | - | - | 3件: 5 5, 7, 127 |
26 | Vizamyl (flutemetamol(F-18)) | 1件: Flutemetamol (18F) Flutemetamol (18F) | - | - | - | 3件: 5 5, 7, 127 |
27 | Xeomin | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 7件: 5 5, 6, 7, 13, 15, 17, 113 |